Search for: "APP Pharmaceuticals, LLC"
Results 41 - 60
of 161
Sort by Relevance
|
Sort by Date
18 Apr 2017, 6:22 am
App. [read post]
5 Apr 2017, 9:08 am
App’x988 (Fed. [read post]
12 Jan 2017, 12:42 pm
.; APP Pharmaceuticals LLC; Pliva Hrvatska D.O.O. [read post]
23 Nov 2016, 12:28 pm
Fresenius, formerly known as APP Pharmaceuticals, LLC, manufactures and sells generic drugs. [read post]
16 Aug 2016, 10:52 am
Wyeth LLC, App. [read post]
3 Aug 2016, 3:51 pm
., a large pharmaceutical company. [read post]
3 Aug 2016, 3:51 pm
., a large pharmaceutical company. [read post]
25 Jul 2016, 7:31 am
Eleison Pharmaceuticals LLC, Docket No. [read post]
19 Mar 2016, 10:13 am
., LLC, 381 F.3d 1142, 1154 (Fed. [read post]
29 Feb 2016, 4:43 pm
BACKGROUND AND PROCEDURAL HISTORY Plaintiffs in Omnicare challenged a registration statement by a pharmaceutical company that included management’s opinions that company contracts were in compliance with federal and state law. [read post]
19 Feb 2016, 11:57 am
Aegis Defense Services, LLC, 976 F. [read post]
1 Feb 2016, 10:43 am
App’x at 297. [read post]
31 Dec 2015, 5:12 am
App. 2015). [read post]
9 Nov 2015, 7:09 am
App. 4th 1188, 1200 (Cal. [read post]
Grieving Parents (Still) Can’t Sue Topix For Son’s Oxy Overdose–Witkoff v. Topix (Forbes Cross-Post)
24 Sep 2015, 10:01 am
App. [read post]
17 Sep 2015, 3:01 pm
App. 2008), review denied (Cal. [read post]
13 Sep 2015, 7:16 am
Mike Mireles, writing on IP Finance, records the potential impact upon the pharmaceutical industry of the current contest to occupy the White House. [read post]
1 Sep 2015, 9:59 pm
.; Teva Pharmaceuticals USA, Inc.; APP Pharmaceuticals, LLC; Barr Laboratories, Inc.; and Pliva Hrvatska D.O.O. sought approval to market (opinion).... [read post]
10 Jul 2015, 6:00 am
App. [read post]
26 May 2015, 7:42 am
Claims such as in Mills, which are at loggerheads with FDA criteria for drug development, are precisely those with the most potential for making pharmaceutical manufacturers into “sitting ducks” for litigation, in this instance litigation based on extraneous genetic factors.It may well be that the coming (and to some extent existing) revolution in genetically individualized medical therapy will require changes in how drugs are evaluated, labeled, etc., but this is a… [read post]
